about
Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicityArgininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humansAcetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity.Lysosomal instability and cathepsin B release during acetaminophen hepatotoxicity.Purinergic receptor antagonist A438079 protects against acetaminophen-induced liver injury by inhibiting p450 isoenzymes, not by inflammasome activationModels of drug-induced liver injury for evaluation of phytotherapeutics and other natural products.Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications.Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice.The gap junction inhibitor 2-aminoethoxy-diphenyl-borate protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes and c-jun N-terminal kinase activationProtection against acetaminophen-induced liver injury by allopurinol is dependent on aldehyde oxidase-mediated liver preconditioningNeutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans.Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humansStrategies for folding of affinity tagged proteins using GroEL and osmolytes.Apoptosis or necrosis in acetaminophen-induced acute liver failure? New insights from mechanistic biomarkers*.Serum Glutamate Dehydrogenase—Biomarker for Liver Cell Death or Mitochondrial Dysfunction?Pathophysiological relevance of neutrophils in acetaminophen hepatotoxicityCaveats of using acetaminophen hepatotoxicity models for natural product testingPathophysiological Relevance of Proteomics Investigations of Drug-Induced Hepatotoxicity in HepG2 Cells
P50
Q34024427-76F9EC78-CDCB-4C9B-9BD7-7DF1FCCB05C1Q34794994-55F8B701-5765-49B0-AE92-C2C624B7920FQ36339274-89BFEA91-37B6-4FE9-B7F0-6879704D8FE9Q36409780-80295055-9110-4CDD-A7B1-8DCC9D5FDADDQ36509045-34259450-8991-4756-9A74-F17AF2E9E114Q36718265-7B543E17-53F5-44FB-B91F-501D7DAC119AQ36844150-C900334A-241F-4671-A05B-F8C6E60EAD84Q37216910-EA105946-E496-4B79-AE58-43DEF3A0EB26Q37381548-A09A6EC8-2E13-40F0-B854-657EE3184037Q37612408-D465254D-9B4F-4CED-9C5E-AE17DF6FFBC2Q37615884-9B39CDA1-19D3-421F-898E-5566BC91FECEQ37624894-53713199-AB1E-4BC4-9049-3DCB65B1D458Q42931919-FE6019E5-95A1-4F1F-91A3-8D3EC68C33A6Q43716245-3B5EFC12-36D1-4F03-9B0C-63CF85DAF487Q57724784-F11DC0FA-3EB6-43C7-9A90-1A6366E36708Q57724794-E9F7910C-6D9C-47C5-8BE1-208BCF3D0F1CQ57724810-066C0BD1-EDE8-45C6-99CD-807FE8C9CE21Q57724827-69108D82-9B76-4DDF-8F53-864755E1868D
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0002-6832-5712
@en
name
Mitchell R McGill
@ast
Mitchell R McGill
@en
Mitchell R McGill
@es
Mitchell R McGill
@nl
type
label
Mitchell R McGill
@ast
Mitchell R McGill
@en
Mitchell R McGill
@es
Mitchell R McGill
@nl
prefLabel
Mitchell R McGill
@ast
Mitchell R McGill
@en
Mitchell R McGill
@es
Mitchell R McGill
@nl
P106
P1153
36464001600
P31
P496
0000-0002-6832-5712